Lineage marking in humanized mice to reveal HIV-1 reservoirs
Lineage marking in humanized mice to reveal HIV-1 reservoirs
批准号:
9321958
负责人:
BENJAMIN K CHEN
金额:
$49.02万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2019-08-31
关键词:
AcuteBiological ModelsCD4 Positive T LymphocytesCell LineCell surfaceCellsDNADataDevelopmentEngineeringExperimental ModelsFibroblastsGene ExpressionGenesGeneticGenetic EngineeringGenetic TranscriptionGoalsHIVHIV InfectionsHIV therapyHIV-1Hematopoietic stem cellsHighly Active Antiretroviral TherapyHumanImmuneImmune systemImmunodeficient MouseInfectionKnowledgeLentivirus VectorMeasuresMediatingMethodsModificationMolecularMolecular ProfilingMusPhenotypePlasmaProvirusesRecombinantsRecording of previous eventsReporterResearchResidual stateStem cellsSurfaceSwitch GenesSystemTimeTransplantationUmbilical Cord BloodViralViral reservoirViremiaVirusVirus Latencyhumanized mousein vivomouse modelnovelnovel strategiespublic health relevancereconstitutionsensortool
中文摘要
描述(由申请人提供):当人类免疫缺陷病毒(HIV)感染被高活性抗逆转录病毒疗法(HAART)控制时,HIV持续存在于免疫细胞库中,难以与类似的未感染细胞区分开来。消除这些细胞的一个关键障碍是确定是什么使这些细胞独一无二。我们假设感染CD4+ T细胞的发育历史受到干扰,即使在HIV潜伏时也可以测量。然而,我们目前无法专门研究储存库细胞状态,因为要确定是否存在病毒,必须激活和改变细胞。为了识别这些细胞,一个理想的实验模型系统将在所有HIV感染细胞中激活一个不可逆的遗传开关,以标记所有感染后存活的细胞。使用人源化小鼠
英文摘要
DESCRIPTION (provided by applicant): When human immunodeficiency virus (HIV) infection is controlled by highly active antiretroviral therapy (HAART), HIV persists in a reservoir of immune cells that are difficult to distinguish from comparable uninfected cells. A key obstacle to eliminating this reservoir is identifying what makes these cells unique. We hypothesize that the developmental history of infected CD4+ T cells is perturbed in ways that can be measured even while HIV is latent. However, we are currently unable to specifically study the reservoir cell states because to determine if virus is present one must activate and alter the cell. To identify these cells an ideal experimental model system would activate an irreversible genetic switch in all HIV infected cells to mark all cells that have survived infection. The use of humanized mice in
research provides an opportunity to genetically manipulate human cells that develop and become infected with HIV in an in vivo context. Immunodeficient mice that are xenografted human immune systems can be infected with HIV and display a progressive decline in CD4 T cells that can be treated with highly active antiretroviral therapy. When treatment is withdrawn plasma viremia rebounds. Here we propose to develop a method to engineer humanized mice engrafted with a human immune system that encodes an irreversible genetic switch to mark latent viral reservoirs. Using state of the art lentiviral transduction we will directly transduce hematopoietic stem cells with the HIV sensor construct. A potential shortcoming of this approach is that this method does not result in the uniform modification of all human cells. In preliminary studies, we describe a major breakthrough in stem cell reprogramming whereby human fibroblasts can directly induced to become human hematopoietic stem cells to generate a multilineage reconstitution of immune cells in when transplanted into NOD/SCID/IL2Rgc-/-(NSG) mice. We will combine this novel approach with recombinant tools that encode sensitive and specific HIV activated switches that are developed in clonal fibroblast lines, and these will be reprogrammed into induced hematopoietic stem cells (iHSC) to create novel humanized mice. The goal of this technological proposal is to develop a genetic reporter mouse model where all infected cells express a GFP lineage marker to physically isolate the reservoir for molecular characterization. We will examine the inducibility of the provirus, the surface phenotype genetically marked cells that have survived HIV infection. With a fluorescent tag on the infected cells, it then becomes possible to obtain the transcriptional profile of these cells t better understand the cellular state that maintains viral persistence. Using this unbiased approach, we hope to discover specific genes and/or cell states that would allow us to target or activate this latent reservoir.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantifying bNAb neutralization of the HIV latent reservoir
-
批准号:10676564
-
项目类别:
-
资助金额:$46.33万
-
财政年份:2023
-
负责人:BENJAMIN K CHEN
-
依托单位:
Faculty Development Core
-
批准号:10494242
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2021
-
负责人:BENJAMIN K CHEN
-
依托单位:
Faculty Development Core
-
批准号:10696176
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2021
-
负责人:BENJAMIN K CHEN
-
依托单位:
Single cell transcriptomics of HIV persistence and latency
-
批准号:10570277
-
项目类别:
-
资助金额:$62.87万
-
财政年份:2021
-
负责人:BENJAMIN K CHEN
-
依托单位:
Single cell transcriptomics of HIV persistence and latency
-
批准号:10721393
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2021
-
负责人:BENJAMIN K CHEN
-
依托单位:
Single cell transcriptomics of HIV persistence and latency
-
批准号:10375603
-
项目类别:
-
资助金额:$62.87万
-
财政年份:2021
-
负责人:BENJAMIN K CHEN
-
依托单位:
Faculty Development Core
-
批准号:10362243
-
项目类别:
-
资助金额:$12.96万
-
财政年份:2021
-
负责人:BENJAMIN K CHEN
-
依托单位:
Single cell transcriptomics of HIV persistence and latency
-
批准号:10600389
-
项目类别:
-
资助金额:$7.0万
-
财政年份:2021
-
负责人:BENJAMIN K CHEN
-
依托单位:
Single cell transcriptomics of HIV persistence and latency
-
批准号:10258566
-
项目类别:
-
资助金额:$63.02万
-
财政年份:2021
-
负责人:BENJAMIN K CHEN
-
依托单位:
HIV immune evasion and escape through T cell virological synapses
-
批准号:10598139
-
项目类别:
-
资助金额:$61.67万
-
财政年份:2020
-
负责人:BENJAMIN K CHEN
-
依托单位:
HIV immune evasion and escape through T cell virological synapses
-
批准号:10484093
-
项目类别:
-
资助金额:$61.67万
-
财政年份:2020
-
负责人:BENJAMIN K CHEN
-
依托单位:
HIV immune evasion and escape through T cell virological synapses
-
批准号:10225070
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2020
-
负责人:BENJAMIN K CHEN
-
依托单位:
Lineage marking in humanized mice to reveal HIV-1 reservoirs
-
批准号:8841967
-
项目类别:
-
资助金额:$21.08万
-
财政年份:2014
-
负责人:BENJAMIN K CHEN
-
依托单位:
Identifying human antibodies that potently neutralize cell-to-cell HIV infection
-
批准号:8728103
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2013
-
负责人:BENJAMIN K CHEN
-
依托单位:
Identifying human antibodies that potently neutralize cell-to-cell HIV infection
-
批准号:8603131
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2013
-
负责人:BENJAMIN K CHEN
-
依托单位:
Imaging Virological Synapses During Parenteral HIV Transmission
-
批准号:8525373
-
项目类别:
-
资助金额:$78.13万
-
财政年份:2009
-
负责人:BENJAMIN K CHEN
-
依托单位:
Imaging Virological Synapses During Parenteral HIV Transmission
-
批准号:8312697
-
项目类别:
-
资助金额:$81.39万
-
财政年份:2009
-
负责人:BENJAMIN K CHEN
-
依托单位:
Mechanisms of highly efficient HIV transfer at virological synapses
-
批准号:7879736
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2009
-
负责人:BENJAMIN K CHEN
-
依托单位:
Imaging Virological Synapses During Parenteral HIV Transmission
-
批准号:8123357
-
项目类别:
-
资助金额:$81.39万
-
财政年份:2009
-
负责人:BENJAMIN K CHEN
-
依托单位:
Imaging Virological Synapses During Parenteral HIV Transmission
-
批准号:7934663
-
项目类别:
-
资助金额:$83.9万
-
财政年份:2009
-
负责人:BENJAMIN K CHEN
-
依托单位:
海外基金